Showing results (51-60 of 335) with videos related to
Sort By:
Pageof 34
Expert Opinion on Investigational Drugs|January 31, 2003
Friedreich's ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?D R RichardsonAntimicrobial Agents and Chemotherapy|September 26, 1997
Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: effects of complexation with copper(II), gallium(III), and iron (III) on their antiproliferative activitiesD R RichardsonBiochimica Et Biophysica Acta|May 16, 1997
Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent processD R RichardsonExpert Opinion on Investigational Drugs|February 28, 2001
The 10th International Conference on Oral Iron Chelators in the treatment of beta-thalassemia and other diseases and biomed meetingD R RichardsonCanadian Journal of Physiology and Pharmacology|February 12, 1998
Potential of iron chelators as effective antiproliferative agentsD R RichardsonArchives of Environmental Health|March 1, 1985
Effects of habitual tobacco smoking on reactive hyperemia in the human handD R RichardsonCiba Foundation Symposium|December 7, 1976
Control of iron delivery to haemoglobin in erythroid cellsP Ponka, J Neuwirt, J Borová, et al.British Journal of Haematology|June 1, 1980
Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazoneM Cikrt, P Ponka, E Necas, et al.The Biochemical Journal|June 1, 1993
Expression of ferrochelatase mRNA in erythroid and non-erythroid cellsR Y Chan, H M Schulman, P PonkaBiochemical Society Transactions|August 28, 2002
Iron targeting to mitochondria in erythroid cellsP Ponka, A D Sheftel, A-S ZhangPageof 34